PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma
Clinical trial NCT02669511 · COMPLETED
Trial details
- NCT number
- NCT02669511
- Sponsor
- PIQUR Therapeutics AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-12
- Primary completion
- 2018-01-12
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.